U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT06821087) titled 'Evaluating the Neuromodulatory Effect of Ketamine in Long COVID' on Feb. 10.
Brief Summary: Plain Language Summary:
This study is a clinical trial to see if ketamine can help treat symptoms of Long COVID, especially fatigue and problems with thinking clearly (often called "brain fog"). Long COVID is a condition that affects people even after they have recovered from COVID-19, causing ongoing health issues like tiredness, memory problems, and difficulty concentrating. Right now, there are very few treatments available for these symptoms, and many people are looking for new options to feel better.
What is the study trying to find ou...